Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Ajai Chari; Saulius Girnius; Saurabh Chhabra; Robert Frank Cornell; Cristina J. Gasparetto; Chatchada Karanes; Matthew A. Lunning; Jeffrey V. Matous; Ruben Niesvizky; Chaim Shustik; Robert K. Stuart; Jason Lih; Yihua Lee; Zeena Salman; Thorsten Graef; Jason Valent

doi:10.1182/BLOOD.V130.SUPPL_1.3111.3111

Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Ajai Chari
, Saulius Girnius
, Saurabh Chhabra
, Robert Frank Cornell
, Cristina J. Gasparetto
, Chatchada Karanes
, Matthew A. Lunning
, Jeffrey V. Matous
, Ruben Niesvizky
, Chaim Shustik
, Robert K. Stuart
, Jason Lih
, Yihua Lee
, Zeena Salman
, Thorsten Graef
, Jason Valent

Icahn School of Medicine at Mount Sinai
University of Cincinnati
Medical College of Wisconsin
Vanderbilt University Medical Center
Duke University
City of Hope National Medical Center
University of Nebraska Medical Center
Myeloma and Plasma Cell Diseases Program, Colorado Blood Cancer Institute, Denver, CO
NewYork–Presbyterian Hospital
McGill University
Medical University of South Carolina
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
Cleveland Clinic

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	130
DOIs	https://doi.org/10.1182/BLOOD.V130.SUPPL_1.3111.3111
State	Published - Dec 7 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Internal Medicine

Access to Document

10.1182/BLOOD.V130.SUPPL_1.3111.3111License: Unspecified

Cite this

Chari, A., Girnius, S., Chhabra, S., Cornell, R. F., Gasparetto, C. J., Karanes, C., Lunning, M. A., Matous, J. V., Niesvizky, R., Shustik, C., Stuart, R. K., Lih, J., Lee, Y., Salman, Z., Graef, T., & Valent, J. (2017). Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood, 130. https://doi.org/10.1182/BLOOD.V130.SUPPL_1.3111.3111

Chari, A, Girnius, S, Chhabra, S, Cornell, RF, Gasparetto, CJ, Karanes, C, Lunning, MA, Matous, JV, Niesvizky, R, Shustik, C, Stuart, RK, Lih, J, Lee, Y, Salman, Z, Graef, T & Valent, J 2017, 'Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma', Blood, vol. 130. https://doi.org/10.1182/BLOOD.V130.SUPPL_1.3111.3111

@article{34b663e9373c48e4bf9e26c3aad8be5f,

title = "Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma",

author = "Ajai Chari and Saulius Girnius and Saurabh Chhabra and Cornell, \{Robert Frank\} and Gasparetto, \{Cristina J.\} and Chatchada Karanes and Lunning, \{Matthew A.\} and Matous, \{Jeffrey V.\} and Ruben Niesvizky and Chaim Shustik and Stuart, \{Robert K.\} and Jason Lih and Yihua Lee and Zeena Salman and Thorsten Graef and Jason Valent",

note = "Ajai Chari, Saulius Girnius, Saurabh Chhabra, Robert Frank Cornell, Cristina J. Gasparetto, Chatchada Karanes, Matthew A. Lunning, Jeffrey V. Matous, Ruben Niesvizky, Chaim Shustik, Robert K. Stuart, Jason Lih, Yihua Lee, Zeena Salman, Thorsten Graef, Jason Valent; Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.",

year = "2017",

month = dec,

day = "7",

doi = "10.1182/BLOOD.V130.SUPPL\_1.3111.3111",

language = "American English",

volume = "130",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

AU - Chari, Ajai

AU - Girnius, Saulius

AU - Chhabra, Saurabh

AU - Cornell, Robert Frank

AU - Gasparetto, Cristina J.

AU - Karanes, Chatchada

AU - Lunning, Matthew A.

AU - Matous, Jeffrey V.

AU - Niesvizky, Ruben

AU - Shustik, Chaim

AU - Stuart, Robert K.

AU - Lih, Jason

AU - Lee, Yihua

AU - Salman, Zeena

AU - Graef, Thorsten

AU - Valent, Jason

N1 - Ajai Chari, Saulius Girnius, Saurabh Chhabra, Robert Frank Cornell, Cristina J. Gasparetto, Chatchada Karanes, Matthew A. Lunning, Jeffrey V. Matous, Ruben Niesvizky, Chaim Shustik, Robert K. Stuart, Jason Lih, Yihua Lee, Zeena Salman, Thorsten Graef, Jason Valent; Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

PY - 2017/12/7

Y1 - 2017/12/7

UR - https://ashpublications.org/blood/article/130/Supplement%201/3111/80562/Initial-Phase-2-Results-of-Ibrutinib-Combined-with

U2 - 10.1182/BLOOD.V130.SUPPL_1.3111.3111

DO - 10.1182/BLOOD.V130.SUPPL_1.3111.3111

M3 - Article

VL - 130

JO - Blood

JF - Blood

ER -

Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Disciplines

Access to Document

Other files and links

Cite this